ES2371340T3 - Preparados líquidos acuosos y preparados líquidos acuosos fotoestables. - Google Patents

Preparados líquidos acuosos y preparados líquidos acuosos fotoestables. Download PDF

Info

Publication number
ES2371340T3
ES2371340T3 ES03771445T ES03771445T ES2371340T3 ES 2371340 T3 ES2371340 T3 ES 2371340T3 ES 03771445 T ES03771445 T ES 03771445T ES 03771445 T ES03771445 T ES 03771445T ES 2371340 T3 ES2371340 T3 ES 2371340T3
Authority
ES
Spain
Prior art keywords
liquid preparation
aqueous liquid
chlorophenyl
pyridyl
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03771445T
Other languages
English (en)
Spanish (es)
Inventor
Masayo Higashiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31184981&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2371340(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2371340T3 publication Critical patent/ES2371340T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES03771445T 2002-07-31 2003-07-30 Preparados líquidos acuosos y preparados líquidos acuosos fotoestables. Expired - Lifetime ES2371340T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002223804 2002-07-31
JP2002223804 2002-07-31

Publications (1)

Publication Number Publication Date
ES2371340T3 true ES2371340T3 (es) 2011-12-30

Family

ID=31184981

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03771445T Expired - Lifetime ES2371340T3 (es) 2002-07-31 2003-07-30 Preparados líquidos acuosos y preparados líquidos acuosos fotoestables.

Country Status (9)

Country Link
US (3) US8784789B2 (de)
EP (1) EP1525884B1 (de)
JP (1) JP3631748B2 (de)
KR (1) KR101016595B1 (de)
CN (1) CN1293880C (de)
AT (1) ATE528003T1 (de)
AU (1) AU2003252746A1 (de)
ES (1) ES2371340T3 (de)
WO (1) WO2004011001A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101011278B1 (ko) * 2005-07-22 2011-01-28 미쓰비시 타나베 파마 코퍼레이션 구강내 속붕괴성 정제
CN103260623B (zh) * 2010-10-06 2016-11-02 伊斯塔制药公司 贝托斯汀组合物
CN103269687B (zh) * 2011-01-04 2016-09-14 伊斯塔制药公司 贝托斯汀组合物
CN104119314B (zh) * 2013-04-23 2018-01-12 重庆华邦制药有限公司 一种稳定的苯磺酸贝他斯汀晶体及其制备方法
CN106038480B (zh) * 2015-04-16 2019-02-22 江苏恒瑞医药股份有限公司 一种光稳定的水性液体制剂

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US4929618A (en) * 1988-03-25 1990-05-29 Ube Industries, Ltd. Piperdine and piperazine derivatives, and antihistaminic pharmaceutical compositions containing the same
US5290774A (en) * 1989-08-03 1994-03-01 Eisai Co., Ltd. Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
JPH0418015A (ja) * 1990-05-10 1992-01-22 Fujikawa Kk 安定なフマル酸クレマスチン水溶液
ZA911813B (en) * 1990-08-09 1991-12-24 Sankyo Co (benzhydryloxyethylpiperidyl)aliphatic acid derivatives and their use in the treatment of allergies and asthma
JP3225976B2 (ja) * 1992-05-29 2001-11-05 キヤノン株式会社 カラー画像形成装置
FI951190A (fi) * 1994-03-15 1995-09-16 Senju Pharma Co Menetelmä pranoprofeenin stabilisoimiseksi ja pranoprofeenin stabiili nestemäinen valmiste
JP3021312B2 (ja) 1994-03-15 2000-03-15 千寿製薬株式会社 プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤
SE9401109D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Opthalmic composition II
US5599534A (en) * 1994-08-09 1997-02-04 University Of Nebraska Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use
JP2929274B2 (ja) 1996-08-15 1999-08-03 エーザイ株式会社 点眼液の光安定化方法
JP3107784B2 (ja) * 1996-12-26 2000-11-13 宇部興産株式会社 光学活性ピペリジン誘導体の酸付加塩及びその製法
TW486475B (en) * 1996-12-26 2002-05-11 Ube Industries Acid addition salt of optically active piperidine compound and process for preparing the same
JP3361713B2 (ja) * 1997-02-26 2003-01-07 大八化学工業株式会社 トリブロモネオペンチルリン酸クロロアルキルエステルの製造方法
ES2206965T3 (es) * 1997-07-29 2004-05-16 Alcon Laboratories, Inc. Composiciones oftalmicas que contienen polimeros de galactomanana y borato.
JPH11228404A (ja) 1997-12-11 1999-08-24 Senju Pharmaceut Co Ltd 安定な水性点眼剤
US6174914B1 (en) 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6369001B1 (en) * 1999-08-11 2002-04-09 Monsanto Technology, Llc Microemulsion coformulation of a graminicide and a water-soluble herbicide
CN1384745A (zh) * 1999-11-01 2002-12-11 爱尔康公司 含有一种氟喹诺酮抗生素和黄原酸胶的药物组合物
JP2001261563A (ja) 2000-03-16 2001-09-26 Cci Corp マトリックスメタロプロテアーゼ産生抑制剤
DE10012732A1 (de) 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
JP3909998B2 (ja) * 2000-03-22 2007-04-25 田辺製薬株式会社 経口投与製剤
AU2001248833A1 (en) 2000-04-24 2001-11-07 Daiichi Pharmaceutical Co., Ltd. Stable liquid preparation
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
KR20030097892A (ko) * 2001-05-25 2003-12-31 에스에스 세야쿠 가부시키 가이샤 의약 배합제
CN102026665A (zh) 2008-05-19 2011-04-20 爱尔康研究有限公司 含有羧基乙烯基聚合物和聚维酮聚合物的药物组合物

Also Published As

Publication number Publication date
US8883825B2 (en) 2014-11-11
US20050107429A1 (en) 2005-05-19
CN1293880C (zh) 2007-01-10
US8784789B2 (en) 2014-07-22
JP3631748B2 (ja) 2005-03-23
EP1525884A4 (de) 2007-10-31
US20150031724A1 (en) 2015-01-29
KR20050025137A (ko) 2005-03-11
KR101016595B1 (ko) 2011-02-22
US20120322825A1 (en) 2012-12-20
JPWO2004011001A1 (ja) 2005-11-24
CN1612734A (zh) 2005-05-04
ATE528003T1 (de) 2011-10-15
US9849121B2 (en) 2017-12-26
AU2003252746A1 (en) 2004-02-16
EP1525884A1 (de) 2005-04-27
WO2004011001A1 (ja) 2004-02-05
EP1525884B1 (de) 2011-10-12

Similar Documents

Publication Publication Date Title
US20210154157A1 (en) Stabilization of epinephrine formulations
JP2016029094A (ja) 座瘡病変の治療のためのアダパレンと過酸化ベンゾイルとの組合せ
ES2960528T3 (es) Formulaciones de epinefrina en aerosol
US11925608B2 (en) Stabilization of epinephrine formulations
JP6818019B2 (ja) レファムリンの注射可能医薬組成物
US9849121B2 (en) Aqueous liquid preparations and light-stabilized aqueous liquid preparations
JP2014214085A (ja) オロパタジン含有水性組成物
JP6148957B2 (ja) プラノプロフェン含有水性組成物
ES2584534A1 (es) Formulación tópica oftálmica de bosentan
ES2414557B1 (es) Composición acuosa de paracetamol para inyección
US6849655B2 (en) Aqueous liquid formulations
JP5753958B2 (ja) 澄明な水性液剤
JP6345492B2 (ja) 点眼剤
KR100611544B1 (ko) 오씨티 제제
US8877168B1 (en) Aqueous liquid preparations and light-stabilized aqueous liquid preparations
JP6224998B2 (ja) オロパタジン含有水性組成物
JP2003055221A (ja) 安定化された組成物
ES2935684T3 (es) Formulaciones de epinefrina intranasales y métodos para el tratamiento de enfermedades
JP2012224629A (ja) ペミロラストを含有する安定な水性組成物
JP6876017B2 (ja) オロパタジン含有水性組成物
JP2012224630A (ja) ペミロラストを含有する安定な水性組成物
ES2350670B1 (es) Composicion veterinaria de ketoprofeno